# clm_2FAB829263B5

subject: Preferred Networks (/record/preferred-networks.md)  
predicate: partnership  
value: PFDeNA  
valid_from: 2018-10-29  
valid_to: null  
published: 2018-10-28  
recorded: 2026-11-08  
confidence: 0.70  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-09  
cite: AsOf. "Preferred Networks partnership: PFDeNA", as of 2018-10-29. Claim clm_2FAB829263B5, https://asof.is/claim/clm_2FAB829263B5, accessed 2026-11-10. Source: https://www.preferred.jp/en/news/pr20181029.  
checked: 2026-11-09 · its source page states the value and the date  

> Oct. 29, 2018, Tokyo Japan – Preferred Networks, Inc. and PFDeNA Inc. will start research and development to create a blood test system that utilizes deep learning technology to detect 14 types of cancers *1 in their early stages.

What https://www.preferred.jp/en/news/pr20181029 says, word for word.

## Sources

- https://www.preferred.jp/en/news/pr20181029 (primary, Preferred Networks, published 2018-10-28)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.